These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 35740534)

  • 1. An Updated Review on EPR-Based Solid Tumor Targeting Nanocarriers for Cancer Treatment.
    Sharifi M; Cho WC; Ansariesfahani A; Tarharoudi R; Malekisarvar H; Sari S; Bloukh SH; Edis Z; Amin M; Gleghorn JP; Hagen TLMT; Falahati M
    Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alliance with EPR Effect: Combined Strategies to Improve the EPR Effect in the Tumor Microenvironment.
    Park J; Choi Y; Chang H; Um W; Ryu JH; Kwon IC
    Theranostics; 2019; 9(26):8073-8090. PubMed ID: 31754382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanodrug Delivery Systems Modulate Tumor Vessels to Increase the Enhanced Permeability and Retention Effect.
    Huang D; Sun L; Huang L; Chen Y
    J Pers Med; 2021 Feb; 11(2):. PubMed ID: 33672813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barriers to drug delivery in solid tumors.
    Sriraman SK; Aryasomayajula B; Torchilin VP
    Tissue Barriers; 2014; 2():e29528. PubMed ID: 25068098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inducible endothelial leakiness in nanotherapeutic applications.
    Ni N; Wang W; Sun Y; Sun X; Leong DT
    Biomaterials; 2022 Aug; 287():121640. PubMed ID: 35772348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Advances in Tumor Targeting via EPR Effect for Cancer Treatment.
    Subhan MA; Yalamarty SSK; Filipczak N; Parveen F; Torchilin VP
    J Pers Med; 2021 Jun; 11(6):. PubMed ID: 34207137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of Submicron CaCO
    Reznik I; Kolesova E; Pestereva A; Baranov K; Osin Y; Bogdanov K; Swart J; Moshkalev S; Orlova A
    Micromachines (Basel); 2024 May; 15(5):. PubMed ID: 38793225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor versus Tumor Cell Targeting in Metal-Based Nanoparticles for Cancer Theranostics.
    Urbano-Gámez JD; Guzzi C; Bernal M; Solivera J; Martínez-Zubiaurre I; Caro C; García-Martín ML
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymersomes as Innovative, Stimuli-Responsive Platforms for Cancer Therapy.
    Negut I; Bita B
    Pharmaceutics; 2024 Mar; 16(4):. PubMed ID: 38675124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymeric Nanoparticles for Drug Delivery.
    Beach MA; Nayanathara U; Gao Y; Zhang C; Xiong Y; Wang Y; Such GK
    Chem Rev; 2024 May; 124(9):5505-5616. PubMed ID: 38626459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [
    Deleuziere M; Benoist É; Quelven I; Gras E; Amiens C
    Molecules; 2024 Mar; 29(7):. PubMed ID: 38611815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using imaging modalities to predict nanoparticle distribution and treatment efficacy in solid tumors: The growing role of ultrasound.
    Cooley MB; Wegierak D; Exner AA
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(2):e1957. PubMed ID: 38558290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanomedicines: Emerging Platforms in Smart Chemotherapy Treatment-A Recent Review.
    Pharmaceuticals (Basel); ; . PubMed ID: 38543101
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.